Specific lipid mediator signatures of human phagocytes: Microparticles stimulate macrophage efferocytosis and pro-resolving mediators

Blood

Volumn 120, Issue 15, 2012, Pages

  Dalli, Jesmond ^a   Serhan, Charles N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DEUTERIUM; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LIPID MEDIATOR; LIPOXIN A; LIPOXIN B; MEDIATOR COMPLEX; PROSTAGLANDIN E2; RESOLVIN D1; RESOLVIN D2; RESOLVIN E2; UNCLASSIFIED DRUG; ZYMOSAN;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL;

EID: 84867753332     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-423525     Document Type: Article

References (50)

1. Majno G, Joris I. Cells, Tissues, and Disease: Principles of General Pathology (2nd Ed). New York, NY: Oxford: Oxford University Press; 2004.
2. Serhan CN. Novel resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol. 2010;177:1576-1591.
3. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871-882.
4. Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D. Resolution of inflammation. Int J Immunopharmacol. 2000;22:1131-1135. (Pubitemid 32012972)
5. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000;192:1197-1204.
6. Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med. 2002;196:1025-1037. (Pubitemid 35231761)
7. Bannenberg GL, Chiang N, Ariel A, et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005;174: 4345-4355. (Pubitemid 40396017)
8. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammationresolution programmes. Nature. 2007;447:869-874. (Pubitemid 46920139)
9. Lu Y, Hong S, Tjonahen E, Serhan CN. Mediatorlipidomics: databases and search algorithms for PUFA-derived mediators. J Lipid Res. 2005;46: 790-802. (Pubitemid 43073289)
10. Serhan CN, Petasis NA. Resolvins and protectins in inflammation- resolution. Chem Rev. 2011;111: 5922-5943.
11. Serhan CN, Dalli J, Karamnov S, et al. Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 2012;26:1755-1765.
12. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirintriggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol. 2011;187: 1957-1969.
13. Chan MM, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol. 2010;184(11):6418- 6426.
14. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol. 2012;165(3):683-692.
15. Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol. 2011;186(3):1735-1746.
16. Titos E, Rius B, Gonzalez-Periz A, et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol. 2011;187(10):5408-5418.
17. White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes. 2010;59(12):3066-3073.
18. Morris T, Stables M, Colville-Nash P, et al. Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci U S A. 2010;107(19):8842- 8847.
19. Morris T, Stables M, Hobbs A, et al. Effects of lowdose aspirin on acute inflammatory responses in humans. J Immunol. 2009;183(3):2089-2096.
20. Psychogios N, Hau DD, Peng J, et al. The human serum metabolome. PLoS One. 2011;6(2): e16957.
21. Raatz SK, Golovko MY, Brose SA, et al. Baking reduces prostaglandin, resolvin, and hydroxyfatty acid content of farm-raised Atlantic salmon (Salmo salar). J Agric Food Chem. 2011;59(20): 11278-11286.
22. Tobin DM, Roca FJ, Oh SF, et al. Host genotypespecific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012; 148(3):434-446.
23. Yang R, Chiang N, Oh SF, Serhan CN. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr Protoc Immunol. 2011;Chapter 14:Unit 14 26.
24. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science. 2010;327(5965):580-583.
25. Norling LV, Spite M, Yang R, Flower RJ, Perretti M, Serhan CN. Cutting edge: humanized nanoproresolving medicines mimic inflammationresolution and enhance wound healing. J Immunol. 2011;186(10):5543-5547.
26. Bellora F, Castriconi R, Dondero A, et al. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A. 2010;107(50):21659- 21664.
27. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191-1197. (Pubitemid 43045627)
28. Kasuga K, Yang R, Porter TF, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol. 2008;181(12):8677-8687.
29. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10(6):427-439.
30. Samuelsson B.An elucidation of the arachidonic acid cascade: discovery of prostaglandins, thromboxane and leukotrienes. Drugs. 1987;33(Suppl 1):2-9. (Pubitemid 17070100)
31. Pouliot M, Gilbert C, Borgeat P, et al. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J. 1998;12(12):1109-1123. (Pubitemid 28418941)
32. Pillai PS, Leeson S, Porter TF, et al. Chemical mediators of inflammation and resolution in postoperative abdominal aortic aneurysm patients. Inflammation. 2012;35:98-113.
33. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612-619. (Pubitemid 32677628)
34. Oh SF, Dona M, Fredman G, Krishnamoorthy S, Irimia D, Serhan CN. Resolvin E2 formation and impact in inflammation resolution. J Immunol. 2012;188:4527-4534.
35. Chiang N, Fredman G, Bäckhed F, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524-528.
36. Ho KJ, Spite M, Owens CD, et al. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol. 2010;177:2116-2123.
37. Wu S-H, Liao P-Y, Yin P-L, Zhang Y-M, Dong L. Elevated expressions of 15-lipoxygenase and lipoxinA4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. 2009;174:115-122.
38. Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyper-responsiveness. J Immunol. 2007;178:496-502. (Pubitemid 46039663)
39. Zimmerman GA, Weyrich AS. Immunology: arsonists in rheumatoid arthritis. Science. 2010; 327(5965):528-529.
40. Marcus AJ. Transcellular metabolism of eicosanoids. Prog Hemost Thromb. 1986;8:127-142.
41. Swirski FK, Nahrendorf M, Libby P. The ins and outs of inflammatory cells in atheromata. Cell Metab. 2012;15(2):135-136.
42. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211(6):609-618.
43. Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol. 2012; 189(5):2597-2605.
44. Nassar GM, Morrow JD, Roberts LJ II, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem. 1994;269:27631-27634. (Pubitemid 24346597)
45. Stables MJ, Shah S, Camon EB, et al. Transcriptomic analyses of murine resolution-phase macrophages. Blood. 2011;118(26):e192-e208.
46. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Schwartzman ML. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280:15267-15278. (Pubitemid 40562883)
47. Yanes O, Clark J, Wong DM, et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol. 2010;6(6):411-417.
48. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364(25):2439-2450.
49. Keyes KT, Ye Y, Lin Y, et al. Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2010;299:H153-H164.
50. Yamada T, Tani Y, Nakanishi H, Taguchi R, Arita M, Arai H. Eosinophils promote resolution of acute periotonitis by producing proresolving mediators in mice. FASEB J. 2011;25:561-568.